Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0029713 (
immaturity
)
4,335
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Granulocyte function may be altered after in vivo G-CSF administration and this has been related to both an
immaturity
of mobilized cells and to a defect in F-actin polymerization. In this paper we show that in resting
Filgrastim
(non-glycosylated G-CSF)-pulsed cells, F-actin polymerization, membrane-linked RhoA and cell polarization are enhanced compared to those found in resting Lenograstim (glycosylated G-CSF)-cells. The basal hyper-activation of RhoA could be responsible for the morphological and functional modifications of
Filgrastim
-mobilized cells. Moreover,
Filgrastim
-mobilized cells, but not Lenograstim-mobilized cells, are unable to correctly respond to LPS stimulation, as demonstrated by minor further RhoA activation and cell elongation.
...
PMID:Glycosylated or non-glycosylated G-CSF differently influence human granulocyte functions through RhoA. 1591 5